These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Can we believe in levosimendan? Follath F Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391 [No Abstract] [Full Text] [Related]
6. Levosimendan: a new option in acute septic cardiac failure? Powell BP; De Keulenaer B Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109 [No Abstract] [Full Text] [Related]
7. Medical support and surgery of the failing heart: levosimendan. Toller W; Knez I Scand J Surg; 2007; 96(2):121-4. PubMed ID: 17679353 [No Abstract] [Full Text] [Related]
8. [Use of levosimendan in acute heart failure and its effect on renal function]. Moyano AP; Hidalgo RL; Grande DB; Morales SC Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016 [No Abstract] [Full Text] [Related]
9. Levosimendan and quality of life. Papadopoulos CE; Zioutas DG; Dalamaga EG Hellenic J Cardiol; 2010; 51(1):81-2. PubMed ID: 20118051 [No Abstract] [Full Text] [Related]
10. Is there a place for levosimendan in the intensive care unit? Simes DC Crit Care Resusc; 2007 Dec; 9(4):395. PubMed ID: 18052906 [No Abstract] [Full Text] [Related]
11. [Is there a role for levosimendan in hospital emergency departments?]. Manzano-Fernández S; Marín F; Garrido Bravo IP; Pascual Figal DA Rev Esp Cardiol; 2008 May; 61(5):545-6; author reply 546. PubMed ID: 18462660 [No Abstract] [Full Text] [Related]
12. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure]. Porcu M; Orrù P Ital Heart J Suppl; 2001 Feb; 2(2):205-6. PubMed ID: 11255888 [No Abstract] [Full Text] [Related]
13. Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients. Parissis JT; Farmakis D; Bistola V; Adamopoulos S; Kremastinos DT Am J Cardiol; 2007 Jan; 99(1):146-7. PubMed ID: 17196480 [No Abstract] [Full Text] [Related]
14. Levosimendan in heart failure after surgical repair of cardiac rupture. Torrado H; Ventura JL; Ruiz-Majoral A; Farrero E; Rodriguez-Castro D; Carrio ML; Miralles A Minerva Cardioangiol; 2009 Feb; 57(1):137-8. PubMed ID: 19202525 [No Abstract] [Full Text] [Related]
15. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
16. Patients with advanced heart failure and the effects of levosimendan. Song ZZ; Ma J Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841 [No Abstract] [Full Text] [Related]
17. Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failure. Mueller T; Gegenhuber A; Haltmayer M Int J Cardiol; 2005 Oct; 104(3):355-6; author reply 357-8. PubMed ID: 15950299 [No Abstract] [Full Text] [Related]
18. [Levosimendan for treatment of heart failure]. Yasumura Y Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380 [No Abstract] [Full Text] [Related]
19. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence? Wikström BG Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671 [No Abstract] [Full Text] [Related]